Dysphagia is an underrecognized but clinically significant complication of CAR-T therapy. Its association with severe treatment-related toxicities and poorer survival suggests the need for routine dysphagia screening and multidisciplinary management in CAR-T treated patients. Early recognition may guide supportive interventions and improve patient outcomes and quality of life.
Abdul-Rahman et al. (Tue,) studied this question.